189 related articles for article (PubMed ID: 35102596)
1. Discovery of an insulin-induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element-binding protein-mediated lipogenesis.
Jiang SY; Yang X; Yang Z; Li JW; Xu MQ; Qu YX; Tang JJ; Li YF; Wang L; Shao YW; Meng XY; Hu H; Song BL; Rao Y; Qi W
Hepatology; 2022 Nov; 76(5):1466-1481. PubMed ID: 35102596
[TBL] [Abstract][Full Text] [Related]
2. ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P.
Kim JY; Garcia-Carbonell R; Yamachika S; Zhao P; Dhar D; Loomba R; Kaufman RJ; Saltiel AR; Karin M
Cell; 2018 Sep; 175(1):133-145.e15. PubMed ID: 30220454
[TBL] [Abstract][Full Text] [Related]
3. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
4. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
[TBL] [Abstract][Full Text] [Related]
5. Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.
Li Y; Zalzala M; Jadhav K; Xu Y; Kasumov T; Yin L; Zhang Y
Hepatology; 2016 Jun; 63(6):1860-74. PubMed ID: 26806650
[TBL] [Abstract][Full Text] [Related]
6. Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.
Rom O; Xu G; Guo Y; Zhu Y; Wang H; Zhang J; Fan Y; Liang W; Lu H; Liu Y; Aviram M; Liu Z; Kim S; Liu W; Wang X; Chen YE; Villacorta L
EBioMedicine; 2019 Mar; 41():62-72. PubMed ID: 30772307
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis.
Kawamura S; Matsushita Y; Kurosaki S; Tange M; Fujiwara N; Hayata Y; Hayakawa Y; Suzuki N; Hata M; Tsuboi M; Kishikawa T; Kinoshita H; Nakatsuka T; Sato M; Kudo Y; Hoshida Y; Umemura A; Eguchi A; Ikenoue T; Hirata Y; Uesugi M; Tateishi R; Tateishi K; Fujishiro M; Koike K; Nakagawa H
J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35380992
[TBL] [Abstract][Full Text] [Related]
8. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression.
Azzu V; Vacca M; Kamzolas I; Hall Z; Leslie J; Carobbio S; Virtue S; Davies SE; Lukasik A; Dale M; Bohlooly-Y M; Acharjee A; Lindén D; Bidault G; Petsalaki E; Griffin JL; Oakley F; Allison MED; Vidal-Puig A
Mol Metab; 2021 Jun; 48():101210. PubMed ID: 33722690
[TBL] [Abstract][Full Text] [Related]
9. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
[TBL] [Abstract][Full Text] [Related]
10. Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2.
Lee EH; Lee JH; Kim DY; Lee YS; Jo Y; Dao T; Kim KE; Song DK; Seo JH; Seo YK; Seong JK; Moon C; Han E; Kim MK; Ryu S; Shin M; Roh GS; Jung HR; Osborne TF; Ryu D; Jeon TI; Im SS
Exp Mol Med; 2024 Apr; 56(4):1001-1012. PubMed ID: 38622198
[TBL] [Abstract][Full Text] [Related]
11. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model.
Ji C; Chan C; Kaplowitz N
J Hepatol; 2006 Nov; 45(5):717-24. PubMed ID: 16879892
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.
Qin X; Xie X; Fan Y; Tian J; Guan Y; Wang X; Zhu Y; Wang N
Hepatology; 2008 Aug; 48(2):432-41. PubMed ID: 18627005
[TBL] [Abstract][Full Text] [Related]
13. Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.
Liu D; Wong CC; Zhou Y; Li C; Chen H; Ji F; Go MYY; Wang F; Su H; Wei H; Cai Z; Wong N; Wong VWS; Yu J
Gastroenterology; 2021 Jun; 160(7):2467-2482.e3. PubMed ID: 33647280
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
[TBL] [Abstract][Full Text] [Related]
15. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
Ren T; Zhu J; Zhu L; Cheng M
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
[TBL] [Abstract][Full Text] [Related]
17. Curcumin protects against high-fat diet-induced nonalcoholic simple fatty liver by inhibiting intestinal and hepatic NPC1L1 expression via down-regulation of SREBP-2/HNF1α pathway in hamsters.
Yang J; Zou J; Mai H; Hong T; Liu H; Feng D
J Nutr Biochem; 2023 Sep; 119():109403. PubMed ID: 37307885
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
19. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
[TBL] [Abstract][Full Text] [Related]
20. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression.
Du R; Xue J; Wang HB; Zhang Y; Xie ML
Eur J Pharmacol; 2011 Sep; 666(1-3):183-8. PubMed ID: 21620823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]